SEARCH

SEARCH BY CITATION

References

  • 1
    Lo KJ, Tong MJ, Chien MC, Tsai YT, Laiw YFK, Yang KG, Chian H, et al. The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan. J Infect Dis 1982; 146: 205210.
  • 2
    Baker LA, Smith C, Liebernian G. The natural history of esophageal vari-ces: a study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding. Am J Med 1959; 29: 228237.
  • 3
    Smith JL, Graham DY. Variceal hemorrhage. A critical evaluation of survival analysis. Gastroenterology 1982; 82: 968973.
  • 4
    Conn HO, Lindenmuth WW, May CJ, Ramsby GR. Prophylactic portacaval anastomosis: a tale of two studies. Medicine (Baltimore) 1972; 51: 2740.
  • 5
    Tsai YT, Lay CS, Lai KH, Ng WW, Yeh YS, Wang JY, Chiang TT, et al. Controlled trial of vasopressin plus nitroglyerin vs vasopressin alone in the treatment of bleeding esophageal varices. Hepatology 1986; 6: 406409.
  • 6
    Lay CS, Tsai YT, Lo KJ, Lee SD, Chen TS, Lee FY. Verapamil-a medical treatment for portal hypertension. Hepatology 1987; 7: 208.
  • 7
    Lay CS, Tsai YT, Kong CW, Lee FY, Chang TT, Lin HC, Yang CM, et al. The influence of Verapamil and Nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites. Clin Phar-macol Ther 1988; 44: 453457.
  • 8
    Groszmann RJ, Kravetz D, Bosch J, Glickman MB, Ruix J, Bredfeldt J, Conn HO, et al. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 1982; 2: 757762.
  • 9
    Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 1981; 305: 13711374.
  • 10
    Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 1981; 80: 518525.
  • 11
    Jackson FC, Perrin EB, Smith AG, Dagradi AE, Nadal HM. A clinical investigation of the portacaval shunt: survival analysis of the prophylactic operation. Am J Surg 1968; 11: 1242.
  • 12
    Paquet KJ, Feussner H. Endoscopic sclerosis and esophageal balloon tam-ponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology 1985; 5: 580583.
  • 13
    Laine L. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices? Hepatology 1995; 22: 663665.
  • 14
    Mundo F, Mitranic, Rodringuez G, Farca A. Endoscopic variceal treatment: is band ligation making over sclerotherapy? [Abstract]. Am J Gastroent-erol 1993; 88: 1496.
  • 15
    Lo GH, Lai KH, Cheng JS, Hwu CH, Chang CF, Chang SM, Chiang HU. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatolgoy 1995; 22: 466471.
  • 16
    Stiegmann GV, Goff JS, Michaletz Onody PA, Korula J, Liebernian D, Saeed ZA, Reveille M, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326: 15271532.
  • 17
    Binmoeller KF, Soehendra N. Nonsurgical treatment of variceal bleeding: new modalities. Am J Gastroenterol 1995; 90:1923-1931.
  • 18
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietronic MC, Williams R. Tran-section of the esophagus for bleeding esophageal varices. Br J Surg 1973; 60: 644649.
  • 19
    Japanese Research Society for Portal Hypertension. The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg 1980; 10: 8491.
  • 20
    Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213218.
  • 21
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457481.
  • 22
    Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 139.
  • 23
    Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187220.
  • 24
    DisonWJ, ed. BMDP Biomedical Computer Programs. Berkeley, CA: University of California Press, 1981.
  • 25
    Buroughs AK, D'Heygere F, Mcintyre N. Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics. Hepatology 1986; 6: 41074113.
  • 26
    Piai G, Cipolletta L, Claar M, Marone G, Bianco MA, Forte G, Iodice G, et al. Prophylactic sclerotherapy of high-risk esophageal varices. Results of multicentric prospective controlled trial. Hepatology 1988; 8: 14951500.
  • 27
    Van Ruiswick J, Byrd JC. Efficacy of prophylactic sclerotherapy for prevention of a first variceal hemorrhage. Gastroenterology 1992; 102: 587597.
  • 28
    Fardy JM, Laupacis A. A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am J Gastroenterol 1994; 89:1983-1984.
  • 29
    North Italian Endoscopic Club for the study and treatment of esophageal varices. Prediction of first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988; 319: 983989.
  • 30
    Sakai P, Malaf FF, Melo JM. Is endoscopic band ligation of esophageal varices contraindicated in Child-Pugh C patients? Endoscopy 1994; 26: 511512.